| Strain Descriptor | Strain Summary | Genotype | Phenotype |
|---|---|---|---|
| forA- | GFP-tagged MhcA in forA null mutant | axeA2, axeB2, axeC2, forA- | |
| forB- | forB- in AX2 | axeA2, axeB2, axeC2, forB- | |
| forC- | forC null mutant in AX2 | axeA2, axeB2, axeC2, forC- | |
| forC- | forC null mutant with the bsR cassette removed | axeA2, axeB2, axeC2, forC- | |
| forC- | forC null cells expressing GFP-forC | axeA2, axeB2, axeC2, forC- | |
| forD- | forD-/forE-/forF-/forH- quadruple null mutant generated by the cre-lox method | axeA2, axeB2, axeC2, forD- | |
| forE- | forE null mutant in AX2 | axeA2, axeB2, axeC2, forE- | |
| forE- | forE/forA double null mutant in AX2 | axeA2, axeB2, axeC2, forE- | |
| forE- | forE/forA/forH triple null mutant in AX2 | axeA2, axeB2, axeC2, forE- | |
| forF- | forF null mutant with a floxed Bsr cassette | axeA2, axeB2, axeC2, forF- | |
| forG- | forG null in AX2-214 | axeA2, axeB2, axeC2, forG- | |
| forH- | forH null mutant; blasticidin resistant | axeA2, axeB2, axeC2, forH- | |
| forH- | GFP-forH expressed in a forH null mutant in a AX2 background | axeA2, axeB2, axeC2, GFP- | |
| fpaA(P143A) | fpaA gene replacement introducing a mutation in P143 (P143A) in AX2; the Pro143 is hydroxylated by P4H1; a P143E mutation has the same effect. | axeA2, axeB2, axeC2, fbpB(P143A), bsR | |
| fpaB- | fpaB / agtA double null mutant in Ax2 | axeA2, axeB2, axeC2, fbpB- | |
| fpaB- | fpaB knockout in AX2, which has a single gene, whereas AX4 has two due to the chr 2 duplication; the blasticidin resistance marker has been removed. | axeA2, axeB2, axeC2, fbpB- | |
| fr1A- | fr1A null mutant in AX2 | axeA2, axeB2, axeC2, fr1A- | |
| fr1C- | fr1C null mutant in AX2 | axeA2, axeB2, axeC2, fr1C- | |
| fr1C- | fr1C/fr1A double null mutant in AX2 | axeA2, axeB2, axeC2, fr1C- | |
| frmA- | frmA null mutant | axeA2, axeB2, axeC2, frmA- | |
| frmA- | frmA null mutant expressing HA-tagged frmA | axeA2, axeB2, axeC2, frmA- | |
| frmA- | GFP expressed in frmA null cells | axeA2, axeB2, axeC2, frmA- | |
| frmB- | frmB null mutant in KAX3 | axeA1, axeB1, axeC1, frmB- | |
| fscE- | fscE null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, fscE- | |
| fslA- | fslA null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, fslA- | |
| fslB- | fslB null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, fslB- | |
| fslH- | fslH null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, fslH- | |
| fslJ- | fslJ REMI mutant; this gene is on the chromosome 2 duplication and both copies have been targeted; the insertion site is 19 bp into the 5th exon; insertion at the upper case DpnII restriction site (GATC) in this sequence: agtgatGATCcatgtaaaag;
get raw sequence data | axeA1, axeB1, axeC1, fslJ- | |
| fslK- | fslK null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, fslK- | |
| fspA- | fspA null mutant expressed in DH-10 cells | axeA1, axeB1, axeC1, pyr5- | |
| fspA- | fspA null mutant expressing C-terminal FLAG-tagged fspA; rescues mutant phenotype | axeA1, axeB1, axeC1, pyr5- | |
| fszA- | fszA null mutant | axeA1, axeB1, axeC1, pyr5- | |
| fszA- | fszA/fszB double null mutant in DH1 | axeA1, axeB1, axeC1, pyr5- | |
| fszA- | fszA null mutant expressing fszA-GFP under the control of the constitutive act15 promoter | axeA1, axeB1, axeC1, fszA- | axe, neoR |
| fszB- | fszB null mutant in AX3 | axeA1, axeB1, axeC1, bsR, fszB- | axe, bsR |
| fszB- | fszB null mutant expressing fszB-GFP under the control of the constitutive act15 promoter | axeA1, axeB1, axeC1, fszB- | |
| Fty- | Mutant strain producing large numbers of tiny fruiting bodies. | matA1 | small fruiting bodies, small colonies |
| fut1- | fut1 REMI mutant | axeA1, axeB1, axeC1, fut1- | |
| G1 | β-Glucosidase mutant | axea1, axeB1, axeC1, gluA1 | axe |
| G1- | tester strain; parents: G1-10, HU26, NP167, and X55 | sprA/ | |
| G12 | beta-glucosidase mutant; tester strain | matA1, axeA1, axeC1, axeB1, gluA12 | |
| G3 | beta-glucosidase mutant: wt:6 units/mg protein, G3: 0.92 units/mg protein; tester strain | matA1, axeA1, axeC1, axeB1, gluA3 | |
| G3gts/ | heterozygote diploid tester strain; Parents: G3gts and X55 | cycA/ | |
| G5 | β-glucosidase mutant (Reversion? See d0961) | axeA1, axeB1, axeC1, gluA5 | axe |
| G5 | tester strain; lousy tsg; some confusion about the phg locus here, could also be phgA1356 | matA1, axeA1, axeC1, axeB1, gluA5 | |
| G5gts1/ | heterozygote diploid tester strain; Parents: G5gts1, HL501, G7gts, X55 | cycA1/ | |
| g6pd- | g6pd REMI mutant; this gene is on the chromosome 2 duplication and both copies have been targeted; insertion site is 36 bp upstream of the stop codon; note, the insertion appears to have deleted a short stretch of genomic DNA; get raw sequence data | axeA1, axeB1, axeC1, g6pd- | |
| gabT- | gabT null mutant | axeA1, axeB1, axeC1, gabT- | |
| gabT- | gabT null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, gabT- | |
| gabT- | gabT null mutant in pkaC overexpressor background | axeA1, axeB1, axeC1, pkaC [K- | |
| gacG- | gacG null mutant in AX2 | axeA2, axeB2, axeC2, gacG- | |
| gacG- | gacG null mutant in AX2 | axeA2, axeB2, axeC2, gacG- | |
| gacH- | gacH null mutant in AX2 | axeA2, axeB2, axeC2, gacH- | |
| gacM/ | REMI mutant; note, the insertion site is in an intergenic region; 356 bp downstream of the gacM gene and 392 downstream of gene DDB_G0287897 | axeA1, axeB1, axeC1, gacM, DDB_G0287897, bsR | |
| gacT- | gacT REMI mutant | axeA1, axeB1, axeC1, gacT- | |
| gacW- | gacW null in AX3 | axeA1, axeB1, axeC1, gacW- | |
| gacW- | gacW(R737A) substitution to deactivate GAP activity in gacW null | axeA1, axeB1, axeC1, gacW- | |
| gacW- | gacW(R988E) substitution to block binding to capping protein in gacW null | axeA1, axeB1, axeC1, gacW- | |
| gadA- | gadA null mutant; blastocidin resistant | axeA1, axeB1, axeC1, gadA- | |
| gadA- | gadA- null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, gadA- | |
| gadA- | gadB- null mutant expressed in gadA- cells | axeA2, axeB2, axeC2, gadA- | |
| gadB- | gadB- null mutant expressed in AX2 cells | axeA2, axeB2, axeC2, gadB- | |
| gapA- | gapA null strain | axeA2, axeB2, axeC2, gapA- | |
| gapA- | gapA null mutant in AX2 | axeA2, axeB2, axeC2, gapA- | |
| gapA- | gapA null mutant | axeA1, axeB1, axeC1, gapA- | |
| gapA- | gapA/iqgC double null mutant | axeA1, axeB1, axeC1, gapA- | |
| gapA- | gapA(K474E) expressed in gapA null | axeA2, axeB2, axeC2, gapA- | |
| gapA- | gapA(R442E) expressed in gapA null | axeA2, axeB2, axeC2, gapA- | |
| gbfA- | gbfA- null mutant (G-box binding factor; DNA binding protein) | axeA1, axeB1, axeC1, pyr5- | axe |
| gbfA- | gbfA null mutant in HMX44A | axe, tsg- | |
| gbfA- | gbfA null mutant | ||
| gbfA- | gbfA null mutant | axeA1, axeB1, axeC1, gbfA- | |
| gbfA- | gbfA- strain transformed with construct carrying actin 15 driven lagC gene. | axeA1, axeB1, axeC1, pyr5- | axe,neoR,agg- |
| gbpC- | knockout of candidate cGMP-binding protein GbpC containing RasGEF domain; blasticidin resistant | axeA1, axeB1, axeC1, pyr5- | |
| gbpC- | gbpC null in DH1 | axeA1, axeB1, axeC1, pyr5- | |
| gbpC- | gbpC null mutant; blasticidin resistant | axeA1, axeB1, axeC1, pyr5- | |
| gbpC- | gbpC- null mutant in AX3 | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | gbpC null mutant in AX3 | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | gbpC/gbpD (candidate cGMP-binding proteins GbpC and GbpD containing RasGEF domains) double null mutant; blasticidin resistant | axeA1, axeB1, axeC1, pyr5- | |
| gbpC- | gbpC overexpressor in gbpC null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | overexpressor of a GbpC mutant with a deletion of the GEF domain in gbpC- null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | gbpC null cells overexpressing gbpC lacking the GRAM domain | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | gbpC null cells expressing the GRAM domain fused to GFP | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | gbpC null cells expressing the GRAM domain containing a G2378A mutation fused to GFP | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | overexpressor of a GbpC mutant with a deletion of the LRR domain in gbpC- null mutant | axeA1, axeB1, axeC1, gbpC, - | |
| gbpC- | overexpressor of a GbpC mutant with an inactive GEF domain in gbpC null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | overexpressor of a GbpC mutant with abolished cGMP binding site in gbpC null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | overexpressor of a GbpC mutant with an inactive Roc domain in gbpC null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpC- | overexpressor of a GbpC mutant with an inactive kinase domain in gbpC null mutant | axeA1, axeB1, axeC1, gbpC- | |
| gbpD- | Knockout of candidate cGMP-binding protein GbpD containing RasGEF domain | axeA1, axeB1, axeC1, pyr5- | axe |
| gbpD- | gbpD under the control of the actin 15 promoter expressed in a gbpD null mutant; neomycin resistant | axeA1, axeB1, axeC1, pyr5- | |
| gbqA- | gbqA REMI mutant | axeA1, axeB1, axeC1, gbqA- | |
| gcA- | gcA- null strain expressed in AX3 | axeA1, axeB1, axeC1, gcA- | |
| gca- | gca-/sgcA- double null mutant in AX3 | axeA1, axeB1, axeC1, gcA- | |
| gca- | gca/sgcA double null mutant in DH1(guanylyl cyclases GCA and sGC) | axeA1, axeB1, axeC1, pyr5- | axe,bsR,reduced chemotaxis |
| GCB- | sgcA- strain from Groningen | axeA1, axeB1, axeC1, sgcA- | axe,bsR |
| gcsA- | gcsA null mutant | axeA1, axeB1, axeC1, gcsA- | |
| gcsA- | carA over-expressed in gcsA null cells | axeA1, axeB1, axeC1, gcsA- | |
| gcsA- | gcsA expressed under the control of the act15 promoter in a gcsA null mutant | axeA1, axeB1, axeC1, gcsA- | |
| gcsA- | yakA over expressed in gcsA null cells | axeA1, axeB1, axeC1, gcsA- |
| Home| Contact dictyBase| SOPs| Site Map |
Supported by NIH (NIGMS and NHGRI)
|
